Drug intelligence / Profile preview

IgG-IRDye800CW

Development stage
Preclinical
Lead developer
LI-COR Biosciences
Modality
Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Intradermal
01

Overview

IgG-IRDye800CW refers to a bioconjugate composed of an immunoglobulin G (IgG) antibody labeled with the near-infrared fluorescent dye **IRDye800CW**. This conjugate is primarily used as an **optical imaging agent** in preclinical and translational research, offering high sensitivity for tumor detection and intraoperative imaging. IgG can be either a non-specific immunoglobulin (control) or a specific monoclonal antibody, depending on the application. The IRDye800CW component provides near-infrared fluorescence (excitation around 785 nm, emission around 803 nm), allowing deep tissue penetration and low background autofluorescence for imaging. The mechanism of action is based on targeted accumulation of the antibody component (via antigen-specific binding if antigen-directed, or via enhanced permeability and retention effect if non-specific) and subsequent detection via the fluorescent label. IgG-IRDye800CW conjugates have been evaluated for **in vivo imaging of tumors** in animal models and have been translated to early phase human clinical research for fluorescence-guided surgery and real-time tumor visualization.

Brand names
IgG-IRDye800IgG-IRDye-800IgG-IRDye 800
Other names
IgG-IRDye800CWIgG-IRDye-800CWIgG-IRDye 800CW

Beyond the preview

Go deeper on IgG-IRDye800CW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IgG-IRDye800CW.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call